Sygnature Discovery
Sygnature Discovery is a leading independent integrated drug discovery and pre-clinical services CRO. Founded in 2004 and private equity-backed since 2017, we operate a fully-enabled research facility in Nottingham, UK, housing nearly 400 staff (80% of our scientists have PhDs). Our experienced R&D scientists possess all the professional skills and know-how required to undertake the most demanding of drug discovery and/or pre-clinical development projects and drive them from target validation, through hit identification, hit-to-lead and lead optimization to development candidate. Sygnature collaborates with its partners via risk share and FTE-based collaborations.
Contact Sygnature Discovery via their website
News Archive
29/06/2021 Five Arrows invests in Sygnature Discovery...more
16/06/2021 Sygnature Discovery expands into early CMC development...more
20/05/2021 Sygnature Discovery gains ISO:27001 certification for information security...more
06/05/2021 Sygnature Discovery appoints Dr David Lustig to spearhead US expansion...more
27/04/2021 Sygnature Discovery expands US presence with Bay Area office...more
25/03/2021 Three of UK's top drug discovery CROs join forces under the name Sygnature Discovery...more
18/02/2021 Sygnature Discovery Creates 2nd Integrated Drug Discovery Site at Alderley Park...more
10/02/2021 Sygnature Discovery & Altasciences join forces for new webinar series...more
05/02/2021 Sygnature Discovery named Company of the Year at Bionow Annual Awards...more
21/01/2021 Sygnature Discovery Strengthens Molecular Design Services...more
19/01/2021 Sygnature Discovery shortlisted for BioNow Company of the Year Award...more
18/01/2021 Sygnature Discovery upgrades western blotting capability...more
08/01/2021 Dr Paul Overton named as Sygnature Discovery's 1st Chief Commercial Officer...more
16/12/2020 Sygnature Discovery £3M investment to expand capabilities...more
10/12/2020 Sygnature Discovery asks What happened? A 2020 Recap!...more
09/10/2020 Sygnature Discovery wins Medilink Outstanding Achievement Award...more
24/09/2020 Sygnature Discovery expands DMPK capabilities with XenoGesis acquisition...more
09/09/2020 Sygnature Discovery appoints Dr Andy Mead at RenaSci...more
23/06/2020 Sygnature Discovery boosts senior management team welcoming Dr Paul Overton...more
11/06/2020 Sygnature assists New York Medical College in Covid-19 fight...more
03/06/2020 Sygnature expands capabilities with acquisition of Alderley Oncology...more
29/05/2020 Sygnature Discovery expands SPR capacity...more
22/05/2020 Sygnature Group adds pharmacology expertise to BD team...more
01/04/2020 Sygnature Discovery Reports Key Appointments and Retirements at RenaSci...more
15/01/2020 Sygnature Discovery strengthens DMPK team...more
09/12/2019 Sygnature Discovery wins Outstanding Achievement Award...more
04/11/2019 Sygnature Discovery invests in high-throughput screening capability...more
12/09/2019 Sygnature Discovery moves US base to Kendall Square...more
09/08/2019 Sygnature Discovery raises over £2,776 for Cancer Research UK...more
06/08/2019 Sygnature Discovery named Finalist in OBN Award for Best CRO...more
29/05/2019 Sygnature Discovery and RenaSci strengthen service-offering...more
28/05/2019 Sygnature Discovery test drive SPR-M...more
17/04/2019 Sygnature Discovery announces collaboration with software firm SilcsBio...more
21/03/2019 Senior appointments enhance Sygnature Discovery's DMPK capabilities...more
12/03/2019 Sygnature creates ScanStation for efficient internal lab management...more
14/08/2018 Sygnature Discovery Establishes Us Office...more
14/08/2018 Sygnature Discovery announces ambitious expansion plans...more
03/08/2018 Sygnature Discovery gains cyber security certification...more
23/07/2018 Sygnature Discovery raises over £2,700 for Parkinson's UK...more
01/07/2018 Sygnature Discovery has appointed Andy Lindstrom as Director of Marketing...more
01/06/2018 Sygnature Discovery appoints Dr Bill Marathias as VP of Business Development for USA...more
26/02/2018 Discovery Building, Sygnature Discovery's HQ, nominated for RICS Awards...more
07/02/2018 Sygnature Discovery to co-host Predictive Toxicology in Discovery DMPK conference...more
19/12/2017 Sygnature Discovery featured on BBC News as a UK life science success...more
09/10/2017 Phoenix Equity Partners announces investment in Sygnature Discovery...more
02/10/2017 Sygnature Discovery forms a strategic alliance with ApconiX...more
27/07/2017 Sygnature Discovery named as Best CRO Finalist in OBN Awards 2017...more
25/07/2017 Sygnature Discovery presented with Queen’s Award for Enterprise 2017...more
28/06/2017 Sygnature Discovery's new HQ is officially open...more
01/06/2017 SelectScience Editorial Article: Insights into Sygnature Discovery...more
16/05/2017 Sygnature Discovery one of London Stock Exchange’s 1000 Companies to Inspire Britain...more
02/05/2017 Sygnature Discovery enhances Biophysics capability...more
21/04/2017 Sygnature Discovery receives a prestigious Queen’s Award for Enterprise...more
07/04/2017 Sygnature Discovery ranked in the Financial Times FT1000f fastest growing companies list...more
30/03/2017 Double celebration for TopiVert and Sygnature Discovery...more
13/03/2017 Sygnature Discovery announces collaboration with Keapstone Therapeutics...more
24/02/2017 Sygnature Discovery in Sunday Times Lloyds SME Export Track 100 for intl. client base...more
01/02/2017 Sygnature Discovery, Mironid, and Peak Proteins to collaborate...more
17/01/2017 Sygnature Discovery announce collaboration with Pelago Bioscience...more
12/10/2016 Sygnature Discovery appoints Ed Browne as Associate Director of DMPK...more
05/10/2016 Sygnature Discovery and Viramatix Announce Anti-Viral Drug Discovery Strategic Alliance...more
21/07/2016 Sygnature Discovery Acquires BMG LABTECH PHERAstar® FSX...more
15/07/2016 Sygnature Discovery Set For Further Growth With Grant From N2 Business Growth Fund...more
04/07/2016 Sygnature Discovery Acquired ImageXpress® Micro Confocal Imaging System...more
16/06/2016 Sygnature Discovery's CEO Wins RSC’s Entrepreneur of the Year Award 2016...more
23/05/2016 Caldan Therapeutics collaborates with Sygnature Discovery...more
15/05/2016 Sygnature Makes Sunday Times Heathrow SME Export Track 100...more
12/05/2016 Caldan Therapeutics Announces Drug Discovery Collaboration with Sygnature Discovery...more
29/04/2016 Topping-out Ceremony for Sygnature's New Discovery Building...more
04/03/2016 Sygnature Discovery to Host Kinase 2016 Event in Nottingham...more
16/02/2016 Sygnature Discovery & RenaSci announce strategic alliance...more
03/02/2016 Sygnature Discovery has delivered 21k+ compounds to European Lead Factory (ELF)...more
30/01/2016 Sygnature Discovery starts 2016 with two key appointments...more
25/01/2016 Sygnature Discovery's group invests in new start up, Peak Proteins...more
10/01/2016 Drug Discovery Today details ELF consortium study featuring Sygnature Discovery...more
08/11/2015 Sygnature will host SCI's 'Young Chemist in Industry'symposium...more
07/10/2015 Ground breaking news for Sygnature Discovery...more
30/07/2015 Sygnature Discovery delivers clinical candidate to Corcept Therapeutics...more
28/07/2015 Sygnature Discovery and Essen BioScience form Strategic Alliance...more
18/05/2015 Sygnature's export growth recognised in national league table...more
07/04/2015 Sygnature Discovery receives French Research accreditation...more
01/02/2015 Sygnature Discovery strengthens team with three key appointments...more
07/12/2014 Sygnature Discovery Welcomes New Associate Director of Bioscience ...more
25/11/2014 Sygnature Discovery Case Study in Creative Quarter publication...more
19/10/2014 Sygnature Discovery Speaker Summaries published from Aspects of Modern Drug Discovery...more
07/10/2014 Sygnature Celebrates 10 Years of Drug Discovery...more
24/04/2014 New Business Development Director at Sygnature Discovery...more
17/10/2013 Sygnature Discovery and Proteros Biostructures Establish Strategic Alliance...more
14/10/2013 Sygnature Discovery wins Business of the Year Award 2013...more
30/09/2013 Sygnature Discovery appoints new Non-Executive Director...more
23/09/2013 Regional Business Award Success for Sygnature Discovery...more
09/09/2013 Sygnature Discovery selected by CellCentric for prostate cancer programme...more
22/08/2013 Sygnature Discovery finalist in Nottinghamshire’s Best Business Awards...more
24/05/2013 Sygnature Discovery wins Nottingham Post Excellence in Science and Technology Award...more
22/04/2013 Sygnature Discovery provided medicinal chemistry support to new CoCo Therapeutics...more
18/04/2013 Sygnature Discovery selected as Business Awards 2013 finalist ...more
21/03/2013 Sygnature Discovery featured on BBC Radio 4‘s "Today" programme...more
07/02/2013 Sygnature Discovery SME Partner in €196 Million European Lead Factory ...more
30/11/2012 Sygnature Discovery Appoints VP, Business Development North America...more
09/10/2012 BerGenBio selects Sygnature Discovery for BGB002 drug development...more
02/10/2012 The Federated CRO Model: delivering Drug Discovery Expertise...more
15/05/2012 Sygnature Discovery and Pneumolabs Establish Strategic Alliance...more
01/03/2012 National Retrosynthesis Competition Sygnature´s Medicinal Chemists are Runners-Up...more
23/01/2012 Sygnature Chemists reach Final in Retrosynthesis Competition ...more
09/01/2012 Sygnature Discovery Nearsourcing article...more
16/12/2011 Sygnature Discovery and Cyprotex Extend Successful Alliance for a Further Two Years ...more
12/12/2011 BioScience Group at Sygnature Discovery is recruiting!...more
05/12/2011 Sygnature Discovery moves into Laboratory #3 ...more
21/11/2011 BBC News Features Sygnature Discovery ...more
31/10/2011 Sygnature Discovery and Saretius Establish Strategic Alliance ...more
06/09/2011 Sygnature Chemical Services becomes Sygnature Discovery...more
08/07/2011 Entrepreneur of the Year Award Winner Simon Hirst...more
09/05/2011 Sygnature Founder Simon Hirst finalist in Nottingham Post Entrepreneur Award ...more
In September 2021 Sygnature Discovery acquired Xenogesis, another BioPartner Programme member. You can see the Xenogesis news archive here: XenoGesis Archive